Compare BSTZ & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSTZ | AXGN |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | N/A | 2013 |
| Metric | BSTZ | AXGN |
|---|---|---|
| Price | $29.44 | $38.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $42.33 |
| AVG Volume (30 Days) | 277.7K | ★ 1.5M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | ★ 8.31% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | N/A | $20.57 |
| Revenue Next Year | N/A | $16.68 |
| P/E Ratio | $41.37 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $20.49 | $11.25 |
| 52 Week High | $31.88 | $46.95 |
| Indicator | BSTZ | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 37.20 |
| Support Level | $28.10 | $29.48 |
| Resistance Level | $31.40 | $39.99 |
| Average True Range (ATR) | 0.93 | 2.71 |
| MACD | -0.13 | -0.81 |
| Stochastic Oscillator | 56.49 | 7.22 |
BlackRock Science and Technology Trust II is a diversified, closed-end management investment company. Its investment objectives are to provide total return and income mainly through long-term capital appreciation. The Trust invests a majority of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement, and use of science and/or technology. Its investment portfolio comprises securities of companies from various industries, such as semiconductors and semiconductor equipment, software, communications equipment, IT services, and entertainment, etc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.